Subscribe

DIGITAL EDITION

ARCHIVES

CURRENT ISSUE

Part 2—Jason Aldred, MD: Understanding Possible Side Effects When Treating Patients with Parkinson’s Disease
Dr. Jason Aldred, owner of Selkirk Neurology in Spokane, WA, discusses the neuropsychiatric effects and dyskinesia that patients may experience when taking Vyalev (foscarbidopa/foslevodopa).
Read More
Part 1—Jason Aldred, MD: Understanding Possible Side Effects When Treating Patients with Parkinson’s Disease
Dr. Jason Aldred, owner of Selkirk Neurology in Spokane, WA, discusses the safety profile of Vyalev (foscarbidopa/foslevodopa), notably injection site reactions and skin considerations.
Read More
January-March 2026 Digital Edition

Click the cover below to access the January-March 2026 Digital Edition

Read More
Letters to the Editor: Post-SSRI Sexual Dysfunction: Challenges and Treatment Approaches

Innov Clin Neurosci. 2026;23(1–3):5–9. Dear Editor: Selective serotonin reuptake inhibitors (SSRIs) have long been a cornerstone in the treatment of mood disorders, particularly depression and anxiety. Since their introduction in

Read More
Letters to the Editor: Response to “Burnout and Ethical Awareness in Mental Health Professionals: A Correlational Study”

Innov Clin Neurosci. 2026;23(1–3):5–9. Dear Editor: We read with great interest the study by Fatima and Ilyas,1 which explores the relationship between ethical awareness and burnout among mental health professionals

Read More
Letters to the Editor: Responding to Correspondence on “Burnout and Ethical Awareness in Mental Health Professionals: A Correlational Study”

Innov Clin Neurosci. 2026;23(1–3):5–9. Dear Editor: We thank Sah and Kumbhalwar for their careful reading of our article, “Burnout and Ethical Awareness in Mental Health Professionals: A Correlational Study,”1 and

Read More